Biote CEO Terry Weber moved to Dallas from Orange County, Calif., in 2018 to lead the hormone replacement therapy provider into its next stage of growth. The Irving-based company is expecting up to ...

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today ...

Revenue: $49.8 million for Q4 2024, up 9% year-over-year. Procedure Revenue Growth: Increased 5%, impacted by transition to new software and training focus. Dietary Supplement Revenue: Increased 10.2% ...

Biote Corp. ( (BTMD)) has held its Q3 earnings call. Read on for the main highlights of the call.

Biote Corp. reported a remarkable 30.4% increase in dietary supplement revenue, reaching $10.7 million. This growth was primarily driven by the expansion of the e-commerce channel, showcasing the ...